© Rosalind Scientific LLC 2018-2022
© Rosalind Scientific LLC, 2018-2022
New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >3,500 drug hunters worldwide, unsubscribe anytime.
<< Back to May
surprisingly well-tolerated clinical molecule
Ph. III candidate in SCLC (4 mg IV QW)
from aerospace compound phenotypic screen
J. Med. Chem., May 27, 2021
EpicentRx Inc., La Jolla, CA
The EpiCentRx Myc and CD47 downregulating molecule with a range of proposed mechanisms, RRx-001, is a Ph. III clinical candidate with an eyebrow-raising chemical structure that originated from an even…
Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.